eFHS Messaging Trial

NCT03516019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2021-02-11

No results posted yet for this study

Summary

In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device.

The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.

Conditions

Interventions

OTHER

personalized notices

The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data. A library of personalized notices with alternative motivational content was developed. Each time a notification is sent, it will be drawn at random from the library.

OTHER

standard notices

The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.

OTHER

am notices

notifications sent at 7 am.

OTHER

pm notices

notifications sent at 7 pm.

OTHER

weekday notices

notifications sent on Wednesday

OTHER

weekend notices

notifications sent on Saturday

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER
  • Boston University

    lead OTHER

Principal Investigators

  • Joanne Murabito, MD ScM · Framingham Heart Study

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-19
Primary Completion
2019-03-23
Completion
2019-03-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516019 on ClinicalTrials.gov